ELSE NUTRITION PROVIDES BI-WEEKLY DEFAULT STATUS REPORT
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) has announced a bi-weekly default status report following the implementation of a Management Cease Trade Order (MCTO) granted by the British Columbia Securities Commission. The MCTO was issued due to delays in completing audit procedures for the company's annual financial statements, MD&A, and AIF for the year ended December 31, 2024.
The order restricts trading activities for the CEO and CFO until the Annual Filings are submitted and the MCTO is lifted, while other shareholders maintain their trading abilities. The company is actively working with auditors to complete the audit and expects to file the required documents by April 23, 2025, with a final deadline of May 30, 2025.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) ha annunciato un rapporto di stato di default bisettimanale a seguito dell'implementazione di un Ordine di Cessazione delle Operazioni di Gestione (MCTO) concesso dalla British Columbia Securities Commission. Il MCTO è stato emesso a causa di ritardi nel completamento delle procedure di revisione per il bilancio annuale della società, la Relazione sulla Gestione e l'AIF per l'esercizio chiuso al 31 dicembre 2024.
L'ordine limita le attività di trading del CEO e del CFO fino alla presentazione dei documenti annuali e alla revoca del MCTO, mentre gli altri azionisti mantengono la possibilità di negoziare. La società sta collaborando attivamente con i revisori per completare la revisione e prevede di depositare i documenti richiesti entro il 23 aprile 2025, con una scadenza finale fissata al 30 maggio 2025.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) ha anunciado un informe de estado de incumplimiento quincenal tras la implementación de una Orden de Suspensión de Comercio para la Dirección (MCTO) otorgada por la Comisión de Valores de Columbia Británica. La MCTO se emitió debido a retrasos en la finalización de los procedimientos de auditoría para los estados financieros anuales de la empresa, el MD&A y el AIF correspondientes al año terminado el 31 de diciembre de 2024.
La orden restringe las actividades de negociación del CEO y CFO hasta que se presenten los informes anuales y se levante la MCTO, mientras que otros accionistas mantienen su capacidad de negociar. La empresa está trabajando activamente con los auditores para completar la auditoría y espera presentar los documentos requeridos antes del 23 de abril de 2025, con una fecha límite final el 30 de mayo de 2025.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF)는 브리티시컬럼비아 증권위원회가 발행한 경영 거래 중지 명령(MCTO) 시행에 따라 격주 기본 상태 보고서를 발표했습니다. MCTO는 2024년 12월 31일 종료된 연도에 대한 회사의 연례 재무제표, 경영진 토론 및 분석(MD&A), 그리고 AIF 감사 절차 완료 지연으로 인해 발행되었습니다.
이 명령은 연례 제출 서류가 제출되고 MCTO가 해제될 때까지 CEO와 CFO의 거래 활동을 제한하며, 다른 주주들은 거래 권한을 유지합니다. 회사는 감사인과 적극 협력하여 감사를 완료하고 2025년 4월 23일까지 필요한 서류를 제출할 예정이며, 최종 마감일은 2025년 5월 30일입니다.
Else Nutrition Holdings (TSX : BABY) (OTCQX : BABYF) a annoncé un rapport de situation de défaut bihebdomadaire suite à la mise en place d'une Ordonnance de Suspension des Transactions de la Direction (MCTO) accordée par la Commission des Valeurs Mobilières de la Colombie-Britannique. La MCTO a été émise en raison de retards dans l'achèvement des procédures d'audit des états financiers annuels, du MD&A et de l'AIF pour l'exercice clos le 31 décembre 2024.
Cette ordonnance restreint les activités de trading du PDG et du CFO jusqu'à la soumission des rapports annuels et la levée de la MCTO, tandis que les autres actionnaires conservent leurs capacités de négociation. La société collabore activement avec les auditeurs pour finaliser l'audit et prévoit de déposer les documents requis d'ici le 23 avril 2025, avec une date limite finale fixée au 30 mai 2025.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) hat nach der Umsetzung einer von der British Columbia Securities Commission erteilten Management-Handelsstopp-Anordnung (MCTO) einen zweiwöchentlichen Statusbericht zum Zahlungsverzug veröffentlicht. Die MCTO wurde aufgrund von Verzögerungen bei der Abschlussprüfung der Jahresabschlüsse, des MD&A und des AIF für das zum 31. Dezember 2024 endende Geschäftsjahr erlassen.
Die Anordnung beschränkt die Handelsaktivitäten des CEO und CFO, bis die Jahresberichte eingereicht und die MCTO aufgehoben wird, während andere Aktionäre weiterhin handeln können. Das Unternehmen arbeitet aktiv mit den Prüfern zusammen, um die Prüfung abzuschließen, und erwartet die Einreichung der erforderlichen Unterlagen bis zum 23. April 2025, mit einer endgültigen Frist am 30. Mai 2025.
- Regular shareholders maintain ability to trade company shares
- Company actively working with auditors to resolve filing delay
- Delay in filing annual financial statements, MD&A, and AIF for 2024
- Implementation of Management Cease Trade Order restricting executive trading
On April 1, 2025, the Company announced in a news release (the "MCTO Announcement") that it has been granted a voluntary cease trade order ("MCTO") by British Columbia Securities Commission in accordance with National Policy 12-203 due to time constraints in completing the audit procedures for the filing of its annual financial statements, management's discussion and analysis ("MD&A") and annual information form ("AIF")(collectively, the "Annual Filings") for the year ended December 31, 2024 on SEDAR within 90 days of its financial year-end. The MCTO prohibits the Chief Executive Officer and Chief Financial Officer from all trading in securities of the Company until such time as the Annual Filings have been filed by the Company and the MCTO has been lifted. The MCTO does not affect the ability of other shareholders of the Company to trade in securities of the Company.
Pursuant to NP 12-203, the Company must file bi-weekly default status reports in the form of further news releases during the period of the MCTO. The Company confirms that since the date of the MCTO Announcement: (i) there has been no material change to the information contained as set out in the MCTO Announcement; (ii) there has been no failure to satisfy the provisions of the alternative information guidelines set out in NP 12-203; (iii) there has not been any other specified default subsequent by the Company under NP 12-203, and (iv) there is no other material information concerning the affairs of the Company that has not been generally disclosed.
The Company reports that it is working diligently with its auditor to complete the audit of the financial statements for the year ended December 31, 2024. The company expects to file its Annual Filings by April 23, 2025, and in any event no later than May 30, 2025, and will issue a news release once they have been filed. Until the filing of the Annual Filings, the Company intends to satisfy the provisions of the alternative information guidelines as required by NP 12-203.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
- "2017 Best Health and Diet Solutions" award at
Milan 's Global Food Innovation Summit - #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category
- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category
- During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon
For more information, visit www.elsenutrition.com or @elsenutrition on Facebook and Instagram.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include but are not limited to, statements with respect to the Company filing its annual financial statements, MD&A and AIF. These forward-looking statements are made as of the date of this press release. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. Although the Company believes the forward-looking statements in this press release are reasonable, it can give no assurance that the expectations and assumptions in such statements will prove to be correct. The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements. Such factors and assumptions include, among others, variations in market conditions; currency exchange rates; the Company's ability to obtain any necessary permits, consents or authorizations required for its activities; the Company's ability to access further funding, to continue its projected growth, or to be fully able to implement its business strategies. In addition, there are known and unknown risk factors which could cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-provides-bi-weekly-default-status-report-302429605.html
SOURCE Else Nutrition Holdings Inc.
FAQ
When will Else Nutrition (BABYF) file its delayed 2024 annual financial statements?
What trading restrictions does the MCTO impose on Else Nutrition (BABYF) shareholders?
What caused Else Nutrition (BABYF) to receive a Management Cease Trade Order?
Which regulatory body issued the MCTO to Else Nutrition (BABYF)?
